537 completed, 285 unknown, 217 recruiting, 88 terminated. 420 Not applicable, 324 Phase 2, 199 Phase 1, 111 Phase 3, 30 Phase 4.
Follow Cervical Cancer: new trials by email Literature Review of Cervical Cancer trials Research Report on Cervical Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC) DOSE-CC Intervention: Educational Sessions - Cervical Cancer Screening, Cervical Cancer | Not applicable | Not yet recruiting | Boston Medical Center | 80000 | 2027-05-01 | 2025-11-10 |
| My Self-Sampling for HPV Awareness, Results, and Empowerment MySHARE+ mHealth Education Intervention, Healthcare Provider Prompt - Cervical Cancer, Cervical Cancer Screening | Not applicable | Not yet recruiting | Daisy Le | 130 | 2027-01-01 | 2026-08-18 |
| Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer Telaglenastat, Radiation treatment, Cisplatin - Advanced Cervical Carcinoma, Cervical Cancer | Phase 2 | Not yet recruiting | Washington University School of Medicine | 42 | 2026-12-31 | 2026-09-03 |
| Vaginal Dose De-escalation During Brachytherapy for Cervical Cancer radiation dose de-escalation - Cervical Cancer | Not applicable | Not yet recruiting | Duke University | 20 | 2026-12-01 | 2026-10-02 |
| COQ10 and Vitamin E for Off-Target Radiation Toxicity Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer | Phase 1 / Phase 2 | Not yet recruiting | University of Nebraska | 200 | 2026-12-01 | 2026-10-08 |
| C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States Qualitative interviews, Focus groups - Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV) | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 3500 | 2026-11-10 | 2026-10-20 | |
| Tucatinib Continuation Study tucatinib - HER2-positive Breast Cancer, Cervical Cancer | Phase 4 | Not yet recruiting | Pfizer | 175 | 2026-11-06 | 2026-08-28 |
| Breast and Cervical Cancer Stigma in Rwanda Behavioral: RISE Intervention, Behavioral: CHW Educational Intervention - Breast Cancer, Cervical Cancer | Not applicable | Not yet recruiting | Dana-Farber Cancer Institute | 1116 | 2026-11-01 | 2026-06-23 |
| Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing Web-Based Health Education - Cervical Cancer, HPV | Not applicable | Not yet recruiting | Sakarya University | 120 | 2026-11-01 | 2026-09-22 |
| Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions Routine-care metastasis-directed radiotherapy - Cervical Cancer, Gynecologic Cancer | Recruiting | Affidea Nu-med Center of Oncological DIagnostics and Therapy | 500 | 2026-10-06 | 2026-10-20 | |
| Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers sample collection - Non Small Cell Lung Cancer, Melanoma (Skin Cancer) | Not applicable | Not yet recruiting | European Institute of Oncology | 360 | 2026-10-01 | 2026-09-11 |
| Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic Surgery DEX 0.2 μg/kg/h., SGB, 0.9% Sodium Chloride (Placebo) - Uterine Fibroids (Leiomyoma), Adenomyosis of Uterus | Not applicable | Recruiting | Catherin Zhang | 100 | 2026-10-01 | 2026-10-06 |
| PEG-rhG-CSF Primary Prophylaxis vs Therapeutic Short-Acting rhG-CSF for Neutropenia During Pelvic Chemoradiotherapy in Cervical or Endometrial Cancer Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor (PEG-rhG-CSF), Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) - Cervical Cancer, Endometrial Cancer | Not applicable | Active not recruiting | The Second Hospital of Anhui Medical University | 90 | 2026-09-15 | 2026-10-08 |
| Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV) Stereotactic Body Radiation Therapy (SBRT), Pembrolizumab, Nivolumab - Head and Neck Cancer, Non-Small Cell Lung Cancer | Phase 2 | Recruiting | Mark Bernard | 35 | 2026-09-09 | 2026-10-14 |
| Postoperative ctHPV-DNA for Recurrence Prediction and Adjuvant Treatment Decision-Making in Cervical Cancer Cervical Cancer, HPV DNA | Not yet recruiting | Anhui Provincial Hospital | 580 | 2026-09-01 | 2026-08-24 | |
| Culturally Adapted Materials to Increase Cervical Cancer Screening Among Polish Women in Iceland Culturally adapted cervical cancer screening invitation letter, Standard cervical cancer screening invitation letter - Cervical Cancer Screening, Cervical Cancer | Not applicable | Not yet recruiting | The Primary Health Care in the Capital Area | 2000 | 2026-09-01 | 2026-10-05 |
| Spatially Fractionated Radiation Therapy for Locally Advanced Cervical Cancer Spatially Fractionated Radiation Therapy, standard of care - Cervical Cancer | Not applicable | Not yet recruiting | The University of Hong Kong-Shenzhen Hospital | 126 | 2026-09-01 | 2026-08-24 |
| Intraoperative Microscopic Assessment of Lymph Node Status in Gynecological Malignancies Gynecologic Cancer, Cervical Cancer | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 160 | 2026-08-01 | 2026-07-14 | |
| Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers HIV (Human Immunodeficiency Virus), AIDS | Not yet recruiting | Shenzhen Third People's Hospital | 1000 | 2026-07-01 | 2026-07-10 | |
| Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer Camrelizumab, Famitinib Malate, Chemotherapy - Cervical Cancer | Phase 2 | Not yet recruiting | Hunan Cancer Hospital | 54 | 2026-06-30 | 2026-06-04 |
Showing 20 of 1311. Sign in to see all of them.
Uterine Cervical Neoplasms (1311) · Ovarian Neoplasms (181) · Endometrial Neoplasms (168) · Breast Neoplasms (118) · Uterine Cervical Dysplasia (113) · Carcinoma, Non-Small-Cell Lung (85) · Papillomavirus Infections (80) · Stomach Neoplasms (73) · Colorectal Neoplasms (72) · Vulvar Neoplasms (70) · Esophageal Neoplasms (64) · Lung Neoplasms (62) · Vaginal Neoplasms (62) · Uterine Neoplasms (59) · Melanoma (58)
Genital Diseases (1311) · Female Urogenital Diseases (1310) · Female Urogenital Diseases and Pregnancy Complications (1310) · Urogenital Diseases (1310) · Urogenital Neoplasms (1308) · Neoplasms by Site (1307) · Genital Diseases, Female (1306) · Genital Neoplasms, Female (1306) · Uterine Diseases (1306) · Uterine Cervical Diseases (1302) · Neoplasms (1254) · Uterine Neoplasms (1252) · Pathological Conditions, Signs and Symptoms (214) · Endocrine Gland Neoplasms (212) · Endocrine System Diseases (212)
Cisplatin (111) · Radiotherapy (51) · Paclitaxel (50) · Carboplatin (46) · pembrolizumab (44) · Brachytherapy (41) · Bevacizumab (27) · Surveys and Questionnaires (24) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (22) · Topotecan (16) · Blood Specimen Collection (14) · atezolizumab (14) · Colposcopy (13) · Docetaxel (13) · Drug Therapy (12)
M.D. Anderson Cancer Center (36) · Gynecologic Oncology Group (25) · National Cancer Institute (NCI) (24) · Merck Sharp & Dohme LLC (19) · Huazhong University of Science and Technology (15) · Memorial Sloan Kettering Cancer Center (15) · Peking Union Medical College Hospital (15) · Duke University (14) · National Taiwan University Hospital (13) · Sun Yat-sen University (11) · Washington University School of Medicine (11) · Tata Memorial Hospital (10) · UNC Lineberger Comprehensive Cancer Center (10) · Xiamen University (10) · Asan Medical Center (9)
United States (471) · China (261) · Canada (71) · France (70) · United Kingdom (55) · South Korea (53) · Italy (47) · Spain (42) · Taiwan (42) · Belgium (36) · Germany (34) · Australia (33) · Netherlands (31) · India (29) · Brazil (23)
Michele Follen, MD, PhD (7) · Kathleen Schmeler, MD (6) · Ting Wu, Ph. D. (6) · Chi-An Chen, MD (5) · Ding Ma, MD, PhD (5) · Lei Li, M.D. (5) · Brigitte E. Miller, MD (4) · Ding Ma (4) · Dongling Zou, M.D. (4) · Jun Zhang, Master (4) · Jun Zhang, master (4)
PMID 41276263, PMID 19236277, PMID 19236279, PMID 19935017, PMID 30380365, PMID 30982556, PMID 32184277, PMID 32779730, PMID 37650664, PMID 41166720, PMID 20949623, PMID 21471141, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23632723, PMID 25071111, PMID 26348120, PMID 26438146, PMID 27432417, PMID 29074187, PMID 29995724, PMID 33326342, PMID 38416430, PMID 42580817, PMID 11224527, PMID 11230468, PMID 11901547, PMID 11919208, PMID 12011138, PMID 12713990, PMID 12821360, PMID 14615449, PMID 14766258, PMID 14984966, PMID 15047228, PMID 15050330, PMID 15240681, PMID 15310778, PMID 15589587, PMID 15712779, PMID 15805295, PMID 15863167, PMID 15911864, PMID 15911865, PMID 16110319, PMID 16150255, PMID 16216315, PMID 16230678, PMID 16234512
2023 (9), 2019 (7), 2018 (6), P01CA082710 (4), P30CA016672 (4), P30CA043703 (4), 2015 (3), 2017 (3), 2025 (3), U24CA275417 (3), 2008 (2), 2009 (2), 2016 (2), P30CA015704 (2), R01CA103830 (2)